Local suppression of IL-17a in the lung of a model with lung cancer showed improved anti-tumor immunity featured by the enhanced IFNγ, a reduced number of T-regulatory cell and the inhibited tumor growth [31]. This evidence concerns the gene IL17A and lung carcinoma.